Oncology Institute (DFPH) Total Non-Current Liabilities (2020 - 2026)

Oncology Institute (DFPH) has 7 years of Total Non-Current Liabilities data on file, last reported at $184.5 million in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 16.17% year-over-year to $184.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $184.5 million (up 16.17% YoY) and the FY2025 annual result came in at $167.8 million, down 0.57% from the prior year.
• Total Non-Current Liabilities rose to $184.5 million in Q1 2026, from $167.8 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $184.5 million in Q1 2026 to a low of $56.0 million in Q2 2022.
• A 5-year average of $146.0 million and a median of $154.9 million in 2022 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 707.11% — and 2023, when it declined 5.72%.
• Tracing DFPH's Total Non-Current Liabilities over 5 years: stood at $134.5 million in 2022, then grew by 12.87% to $151.8 million in 2023, then increased by 11.12% to $168.7 million in 2024, then slipped by 0.57% to $167.8 million in 2025, then climbed by 9.96% to $184.5 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $184.5 million (Q1 2026), $167.8 million (Q4 2025), and $162.2 million (Q3 2025), per Business Quant data.